Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
20.00    0.00 (0.00%)
Bid:
19.00
Ask:
21.00
Spread: 2.00 (10.526%)
Market Cap: £43.80m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Trading Update for 2021

13 Jan 2022 07:00

RNS Number : 2927Y
Steppe Cement Limited
13 January 2022
 

13 January 2022

Steppe Cement Ltd

Preliminary Update for the Year ended 31 December 2021

Steppe Cement Limited ("Steppe Cement") recorded good revenue growth in 2021 with positive market conditions for the business. The focus has been on the domestic market where Steppe Cement's market share remains resilient.

The recent changes within the Kazakh Government, as well as the disturbances in the main cities, have not affected the continuous operations of the cement factory.

Steppe Cement recorded revenue for the year ended 31 December 2021 of 36,020 million Tenge ("KZT"), which was 16% higher than the KZT 30,958 million recorded for the previous year. In 2021, cement sales volume was 1,688,544 tonnes, higher than the 1,645,744 tonnes achieved for the previous year. The average price (ex-VAT) for delivered cement was KZT 21,332 per tonne in 2021, representing a 13% increase on the KZT 18,811 per tonne achieved in 2020. The average ex-factory price in 2021 stood at KZT 18,134 per tonne compared to 15,760 in 2020, which represents USD 43 per tonne based on 2021's average exchange rate of USD/KZT 426 vs 413 in 2020. As we were limited by our production, we concentrated in the markets closer to our factory.

In 2021, the cement market consumption in Kazakhstan increased by 23% to 11.6 million tonnes from 9.4 million tonnes in 2020. This unexpectedly big increase in domestic demand has been the consequence of the changing in the withdrawal policy for pension funds. Citizens were allowed, under certain conditions, to allocate money from their pension funds to property or health.

Steppe Cement's local market share was 13.9%. Exports decreased by 57.2% from 202,000 tonnes in 2020 to 86,500 tonnes in 2021. Overall, Kazakhstan imported 0.8 million tonnes of cement (vs 0.6 million tonnes in 2020) and exported 1.6 million tonnes (vs 2.0 million tonnes in 2020).

We have a healthy cash balance and are continuing our capex program to increase the production capacity of the Company by 5% by the summer of 2022.

We are in the period of lowest sales of the year, and the directors do not believe they presently have sufficient visibility on economic matters to make an accurate prediction on demand for 2022.

The full results and audited accounts denominated in USD are expected to be published in May 2022.

Steppe Cement's AIM nominated adviser and broker is RFC Ambrian Limited.

Nominated Adviser contact: Stephen Allen or Andrew Thomson on +61 8 9480 2500.

Broker contact: Charlie Cryer at +44 20 3440 6800

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBJMTTMTMBMRT
Date   Source Headline
27th May 20267:00 amRNSNotice of AGM
27th May 20267:00 amRNSAnnual Financial Report
10th Apr 20267:00 amRNSTrading Update for the Quarter ended 31 March 2026
19th Jan 20268:03 amRNSInvestor Presentation via Investor Meet Company
15th Jan 20263:02 pmRNSReplacement - Trading Update
15th Jan 202610:45 amRNSTrading Update, Board Changes and Investment Plan
29th Dec 20257:00 amRNSCapital Repayment Payment Date
29th Dec 20257:00 amRNSCapital Repayment Payment Date
9th Dec 202510:30 amRNSCapital Repayment Record Date
5th Dec 20259:17 amRNSResult of EGM
14th Nov 20257:00 amRNSProposed Reduction & Repayment of Capital and EGM
17th Oct 20257:00 amRNSTrading Update for Q3 2025
15th Sep 20257:00 amRNSHalf-year Report
25th Jul 202511:07 amRNSResult of AGM
21st Jul 20251:34 pmRNSAGM – Submission of Shareholder Questions
7th Jul 20258:00 amRNSTrading Update
26th Jun 20257:55 amRNSNotice of AGM
26th Jun 20257:54 amRNSAnnual Financial Report
8th Apr 20258:29 amRNSTrading update for the quarter ended 31 March 2025
14th Jan 20257:00 amRNSYear End Trading Update
2nd Jan 202510:00 amRNSCapital Repayment Payment
12th Dec 20247:00 amRNSCapital Repayment Record Date
6th Dec 20248:39 amRNSResult of EGM
15th Nov 20247:00 amRNSProposed Reduction & Repayment of Capital and EGM
14th Oct 20247:00 amRNSTrading Update for Q3 2024
4th Oct 20249:15 amRNSHolding(s) in Company
20th Sep 20247:00 amRNSHalf-year Report
6th Aug 20248:21 amRNSDirector's Dealing
2nd Aug 20249:44 amRNSDirector's Dealing
12th Jul 202410:08 amRNSResult of AGM and Market Update for H1 2024
4th Jul 20247:00 amRNSAGM - Submission of Shareholder Questions
19th Jun 20247:00 amRNSNotice of AGM
19th Jun 20247:00 amRNSAnnual Financial Report
23rd May 20247:00 amRNSCapital Repayment Record Date
26th Apr 20249:53 amRNSResult of EGM
9th Apr 20249:42 amRNSDirector's Dealing
5th Apr 20247:01 amRNSProposed Return of Cash to Shareholders and EGM
5th Apr 20247:00 amRNSTrading update for the quarter ended 31 March 2024
12th Jan 202410:15 amRNSYear End Trading Update
13th Dec 20239:15 amRNSUpdate re intention to pay a dividend
28th Nov 202311:44 amRNSDirector's Dealing
23rd Nov 20237:41 amRNSDirector's Dealing
11th Oct 20239:44 amRNSMarket Update for the Third Quarter September 2023
20th Sep 202310:19 amRNSDirector's Dealing
19th Sep 20239:00 amRNSHalf-year Report
13th Jul 20237:00 amRNSResult of AGM
12th Jul 20237:00 amRNSMarket Update - First half of 2023
4th Jul 20237:00 amRNSNotice of AGM and Submissions of Questions
9th Jun 20237:00 amRNSNotice of AGM
9th Jun 20237:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.